WINNERS & LOSERS: Tullow falls as oil down; Thungela swings to loss
23rd Mar 2026 11:50
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More
| Price | 0.24p on 22-04-2026 at 08:00:12 |
|---|---|
| Change | -0.012p -4.76% |
| Buy | 0.25p |
| Sell | 0.23p |
| Last Trade: | Buy 183,429.00 at 0.2426p |
| Day's Volume: | 441,682 |
| Last Close: | 0.252p |
| Open: | 0.24p |
| ISIN: | GB00BD5H8572 |
| Day's Range | 0.24p - 0.24p |
| 52wk Range: | 0.1785p - 0.775p |
| Market Capitalisation: | £10.30m |
| VWAP: | 0.243802p |
| Shares in Issue: | 4.29b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Oxford Biodyn (OBD) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 183,429 | 0.2426p | Ordinary |
08:57:41 - 22-Apr-26 |
| Buy* | 21,060 | 0.25p | Ordinary |
08:42:18 - 22-Apr-26 |
| Buy* | 5,588 | 0.25p | SI Trade |
08:42:17 - 22-Apr-26 |
| Buy* | 472 | 0.25p | SI Trade |
08:42:17 - 22-Apr-26 |
| Buy* | 5,000 | 0.25p | SI Trade |
08:42:17 - 22-Apr-26 |
| Buy* | 10,000 | 0.25p | SI Trade |
08:42:17 - 22-Apr-26 |
| Buy* | 420 | 0.25p | Ordinary |
08:34:07 - 22-Apr-26 |
| Buy* | 4,000 | 0.25p | Ordinary |
08:33:15 - 22-Apr-26 |
| Buy* | 20,610 | 0.2426p | Ordinary |
08:31:35 - 22-Apr-26 |
| Buy* | 144,270 | 0.2426p | Ordinary |
08:30:12 - 22-Apr-26 |
Oxford Biodyn (OBD) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 15th Apr 2026 7:00 am | RNS | Board Appointment |
| 30th Mar 2026 4:07 pm | RNS | Holding(s) in Company |
| 20th Mar 2026 12:03 pm | RNS | Holding(s) in Company |
| 3rd Mar 2026 9:30 am | RNS-R | OBD to present at PMWC 2026 |
| 17th Feb 2026 7:00 am | RNS | Change of Nominated Adviser |
| 27th Jan 2026 12:52 pm | RNS | Holding(s) in Company |
| 26th Jan 2026 12:10 pm | RNS | Result of AGM |
| 26th Jan 2026 7:00 am | RNS | Board Change |
| 22nd Dec 2025 11:00 am | RNS | Publication of 2025 Annual Report |
| 22nd Dec 2025 11:00 am | RNS | Publication of 2025 Annual Report |